Research ID
hum0406-v1Release info
Research title
The Generation of Human Disease-Specific iPS Cells and the Use of Such iPS Cells for Disease Analysis
Research overview
- Aims
- The ideal way of studying the disease is to use an affected part (tissue) of the patient's body. However, the use of the affected tissue involves many issues; for example, sampling of the affected tissue may impose a severe burden on the patient or is sometimes technically impossible. Therefore, iPS cells are a powerful technology that can differentiate into the various tissues that make up our bodies. The aim of this study is to generate iPS cells from patients' and/or their family members' somatic cells and to use them together with clinical information to discover more about the cause of the diseases and to develop new effective treatments.
To elucidate the molecular mechanisms underlying the pathology of Primary Ciliary Dyskinesia (PCD) caused by disease-associated gene variants. To this end, we will establish patient-specific iPSCs and gene-corrected iPSC lines, differentiate them into airway epithelial cells, and perform single-cell RNA sequencing for comparative transcriptomic analysis. - Methods
- [JGAS000617 / E-GEAD-623] Patient iPSC-derived type 2 alveolar epithelial (iAT2) cells (EpCAM+CPM+) and fibroblasts (EpCAM-CPM-) were isolated by fluorescence-activated cell sorting. Total RNA was extracted from the cells and sequenced.
[JGAS000846] Airway epithelial cells derived from human iPSCs (disease-specific: PCD-iPSC; gene-corrected: CCE1-iPSC) were differentiated under air-liquid interface (ALI) conditions and subjected to single-cell RNA sequencing (scRNA-seq). - Participants/materials
- [JGAS000617 / E-GEAD-623] Familial interstitial pneumonia with SFTPC variant: 1 case
- EpCAM+CPM+ or EpCAM-CPM- cells of alveolar organoids derived from iPSCs established from PBMCs of a familial interstitial pneumonia patient with Y104H variant of SFTPC
- EpCAM+CPM+ or EpCAM-CPM- cells of Y104H-KO iPSC-derived alveolar organoids established from PBMCs of the patient with Y104H variant of SFTPC
[JGAS000846] Primary Ciliary Dyskinesia with a CCNO (Cyclin O) Variant: 1 case
1. Airway epithelial cell sheet derived from iPSCs established from the patient's peripheral blood
2. Airway epithelial cell sheet derived from gene-corrected iPSCs established from the patient's peripheral blood - URL
- N/A
Datasets
The list is the one this version published; each dataset's content is shown as it is now.
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000746 | NGS (RNA-seq) |
| Controlled-access (Type I) | 2023-08-30 | |
| E-GEAD-623 | NGS (RNA-seq) |
| Unrestricted-access | 2023-08-30 |
Data provider
- Principal investigator
- Shimpei Gotoh
- Affiliation
- Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University
Research projects
No research projects.
Grants
| Name | Title | Project number |
|---|---|---|
Research Center Network for Realization of Regenerative Medicine, Japan Agency for Medical Research and Development (AMED) | Application of human iPS cells for disclosing the pathogenic mechanisms of intractable respiratory diseases and finding novel therapeutic agents |
|
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC | ||
Deuterosomal cells are the responsible lineage for multiciliogenesis in human airway differentiation* |
Controlled access users
No use of the controlled access data has been recorded.